Panel Discussion: Improving Long-Acting Therapy Success Rates Through Real-World Lessons in Durability, Translation & Development

12:30 pm - Wednesday 20th January 2027

  • Join experienced developers and researchers of long-acting ocular therapies to explore lessons from ongoing development to avoid common pitfalls and accelerate development
  • Understand why promising durability data often fails to translate from preclinical studies into clinical success and learn how to generate more predictive evidence earlier in development
  • Learn how to overcome formulation, delivery, inflammation, and safety challenges while improving durability, efficacy, and patient experience
  • Discuss practical strategies for managing development risk, investment timelines, and key decision points to improve long-term clinical and commercial success

Speakers:

Executive Director, Drug Delivery & Devices
Eli Lilly & Co
Head of Translational Medicine
Apellis Pharmaceuticals
Executive Director, Device Development
Genentech
Chief Discovery & Development Advisor
NeuParadigmBio